This book aims to make the sometimes difficult-to-understand theories more understandable. The author achieves this in an engaging and often amusing way; you can never have too many song lyrics in a book to help the reader understand the wider...
This paper presents results of BC devices in very young children and helps inform an honest discussion of risks / benefit with prospective parents. The authors of this article from Starship Children’s Hospital, Auckland, New Zealand have a series of...
Otitis media with effusion (OME), also known as glue ear, is a common cause of hearing loss in children. Most cases resolve spontaneously within three months. Early and proper management of OME can help avoid hearing and speech impairment that...
In this Egyptian study, the authors looked at the hearing outcomes in patients who underwent ossiculoplasty with cartilage interposition versus those with partial ossicular replacement prosthesis (PORP). They looked at a total of 47 ears from 45 consecutive patients with...
Universal newborn hearing screening has allowed early diagnosis and, subsequently, early intervention in hearing loss. In 2020 the Food and Drug Administration candidacy criteria for cochlear implants (CI) expanded to include profound sensorineural hearing loss (HL) in children as young...
Oussoren et al performed a systematic review and meta-analyses of current literature on the above topic: specifically, cardiovascular risk factors for developing idiopathic sudden sensorineural hearing loss (iSSNHL), the presence of white matter hyperintensities in patients with iSSNHL and the...
For ENT practitioners looking to offer patients additional emotional support and links to a reliable peer network, the Hearpeers community and its volunteer mentors are now available globally.
For individuals with moderate-to-profound sensorineural hearing loss, cochlear implants are a highly effective form of hearing rehabilitation. Despite their effectiveness, utilisation is low, with approximately only 12.7% of suitable adult candidates receiving implants. Barriers to access include the geographic distribution...
Neuromod, an Irish medical device company specialising in tinnitus, has closed a €10 million equity financing deal in a Series B fundraising expansion to expand the availability of tinnitus treatment device, Lenire. Financing was oversubscribed and led by existing investors...
1 January 2019
| Jérome R Lechien, Daniele De Siati
|
ENTA - General
Brussels has a proud history in the world of ENT. Jérome Lechien, who is on the Communications Committee for the CEORL-HNS 2019 Congress, and Daniele de Siati, a member of the international Scientific Committee, give us a history lesson and...